NCT07075718Phase 2Recruiting

Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Study sponsor: Glaukos Corporation

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-03Estimated
Enrollment · participants110Estimated
Source updated2026-09-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment decreased by 500 participants

Before: 610 participants (planned). After: 110 participants (planned).

Phase changed

Before: PHASE2, PHASE3. After: PHASE2.

Check registry source